Ubs Asset Management Americas Inc Amneal Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 470,432 shares of AMRX stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
470,432
Previous 334,956
40.45%
Holding current value
$4.89 Million
Previous $2.81 Million
35.6%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
144MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$182 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$128 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$122 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$117 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$58.4 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.57B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...